Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,582Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Toviaz

PharmaCompass

01

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Toviaz

arrow
BIO Asia-Taiwan
Not Confirmed

Fesoterodine Fumarate

Main Therapeutic Indication : Nephrology

Currency : USD

2019 Revenue in Millions : 250

2018 Revenue in Millions : 271

Growth (%) : -8

blank

02

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

03

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Toviaz

arrow
BIO Asia-Taiwan
Not Confirmed

Fesoterodine Fumarate

Main Therapeutic Indication : Nephrology

Currency : USD

2021 Revenue in Millions : 238

2020 Revenue in Millions : 252

Growth (%) : -6

blank

04

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

05

Brand Name : Toviaz

Fesoterodine fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

06

Brand Name : Toviaz

Fesoterodine fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

07

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Toviaz

arrow
BIO Asia-Taiwan
Not Confirmed

Fesoterodine Fumarate

Main Therapeutic Indication : Urology

Currency : USD

2016 Revenue in Millions : 258

2015 Revenue in Millions : 267

Growth (%) : -3

blank

08

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

09

Brand Name : Toviaz

Fesoterodine Fumarate

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Toviaz

arrow
BIO Asia-Taiwan
Not Confirmed

Fesoterodine Fumarate

Main Therapeutic Indication : Renal Disorders

Currency : USD

2018 Revenue in Millions : 270

2017 Revenue in Millions : 257

Growth (%) : 5%

blank